Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac Lot Consistency in Children
NCT05112913Phase 4Active, not recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jul 2021
- Primary completion
- Nov 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Started Jul 2021; status: active, not recruiting.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05112913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05112913.